- Home
- Profiles
Jay C Unkeless, PhD
- About Me
- Research
- Locations
- Publications
- Industry Relationships
About Me
Language
Position
About Me
Language
Position
Research
A major aim of the laboratory is to analyze signaling pathways leading from Fc[gamma]R activation (by crosslinking) to cell effector activity. In particular, we are interested in the signaling mechanisms of glycan-phosphatidyl inositol-anchored Fc[gamma]R IIIb, and with the architecture of Fc[gamma]RIIIb in the plasma membrane. We have recently observed that crosslinking Fc[gamma]RIIIb results in the co-capping of Fc[gamma]RIIa and in the rapid partition into the Fc[gamma]RIIIb cap of a lipid probe, dI-I, that is initially diffusely distributed in the plasma membrane. It is thus likely that GPI-anchored protein capping results in a lipid membrane domain with significantly different physical properties from the bulk membrane. The properties of these domains, and the proteins that associate with the capped Fc[gamma]RIIIb caps are under investigation.
\r\n\r\nFollowing our interest in phagocytosis, we have derivsed a screen for proteins that bind inositol hexaphosphate (IP6) and have probed a recently constructed macrophage expression library with a multivalent complex consisting of biotinylated IP6 conjugated to 125I-BSA. We have identified a serine/threonine kinase reported to be expressed strongly in spermatids, where it associates with microtubule associated proteins. This kinase is likely to be involved with exocytic events. The proteins that interact with the kinase are being studied biochemically, and by yeast two-hybrid interaction analysis. We are also mapping the domain(s) of the protein that bind IP6, and have mapped 5' genomic clones for use in isolating a knockout mutant.
\r\n\r\nWe have developed a system for obtaining synchronous and maximal stimulation of macrophages by Fc[gamma]R ligation to glass, and are screening for transcripts activated by this stimulation. Initial efforts in this direction used differential display PCR (ddPCR), and resulted in the isolation of a protein that may play a role in control of deubiquitination. However, ddPCR is fraught with technical difficulties, and we are now revisiting this problem utilizing a recently developed subtractive hybridization/PCR protocol.
\r\nLocations
Publications
Selected Publications
- Erratum: Editor's note: Toll-like receptors on tumor cells facilitate evasion of immune surveillance (Cancer Research (2005) 65 (5009–5014)). Bo Huang, Jie Zhao, Hongxing Li, Kai Li He, Yibang Chen, Lloyd Mayer, Jay C. Unkeless, Huabao Xiong. Cancer Research
- Erratum: Editor's note: listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling (Cancer Res (2007)67:(4346–4352)Doi: 10.1158/0008-5472.CAN-06-4067). Bo Huang, Jie Zhao, Shiqian Shen, Hongxing Li, Kai Li He, Guan Xin Shen, Lloyd Mayer, Jay Unkeless, Dong Li, Ye Yuan, Gui Mei Zhang, Huabao Xiong, Zuo Hua Feng. Cancer Research
- Notch-1 signaling regulates intestinal epithelial barrier function, through interaction with CD4<sup>+</sup> T cells, in mice and humans. Stephanie Dahan, Keren M. Rabinowitz, Andrea P. Martin, M. Cecilia Berin, Jay C. Unkeless, Lloyd Mayer. Gastroenterology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Unkeless has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.